000			01710 a2200457 4500
005			20250513214211.0
264		0	_c20000815
008			200008s 0 0 eng d
022			_a1097-9336
040			_aNLM _beng _cNLM
100	1		_aRogers, J M
245	0	0	_aRecombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals. _h[electronic resource]
260			_bIn vitro & molecular toxicology _c2000
300			_a67-82 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAndrogens _xpharmacology
650	0	4	_aAnimals
650	0	4	_aBase Sequence
650	0	4	_aBiological Assay _xmethods
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnhancer Elements, Genetic _xgenetics
650	0	4	_aEstrogen Antagonists _xpharmacology
650	0	4	_aEstrogen Receptor Modulators _xanalysis
650	0	4	_aEstrogens _xanalysis
650	0	4	_aFemale
650	0	4	_aGenes, Reporter _xgenetics
650	0	4	_aHumans
650	0	4	_aMolecular Sequence Data
650	0	4	_aOvary _xdrug effects
650	0	4	_aPolychlorinated Biphenyls _xanalysis
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aSensitivity and Specificity
650	0	4	_aSubstrate Specificity
650	0	4	_aTamoxifen _xpharmacology
650	0	4	_aTime Factors
650	0	4	_aTranscriptional Activation _xdrug effects
650	0	4	_aTretinoin _xpharmacology
650	0	4	_aTumor Cells, Cultured
700	1		_aDenison, M S
773	0		_tIn vitro & molecular toxicology _gvol. 13 _gno. 1 _gp. 67-82
999			_c10850704 _d10850704